FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151714333> ?p ?o ?g. }

• W2151714333 endingPage "56" @default.
• W2151714333 startingPage "48" @default.
• W2151714333 abstract "Intravenous thrombolysis for ischaemic stroke remains underused worldwide. We aimed to assess whether our statewide comprehensive stroke management programme would improve thrombolysis use and clinical outcome in patients.In 2008-09, we designed the Tyrol Stroke Pathway, which provided information campaigns for the public and standardised the entire treatment pathway from stroke onset to outpatient rehabilitation. It was commenced in Tyrol, Austria, as a long-term routine-care programme and aimed to include all patients with stroke in the survey area. We focused on thrombolysis use and outcome in the first full 4 years of implementation (2010-13).We enrolled 4947 (99%) of 4992 patients with ischaemic stroke who were admitted to hospitals in Tyrol; 675 (14%) of the enrollees were treated with alteplase. Thrombolysis administration in Tyrol increased after programme implementation, from 160 of 1238 patients (12·9%, 95% CI 11·1-14·9) in 2010 to 213 of 1266 patients (16·8%, 14·8-19·0) in 2013 (ptrend 2010-13<0·0001). Differences in use of thrombolysis in the nine counties of Tyrol in 2010 (range, 2·2-22·6%) were reduced by 2013 (12·1-22·5%). Median statewide door-to-needle time decreased from 49 min (IQR 35-60) in 2010 to 44 min (29-60) in 2013; symptomatic post-thrombolysis intracerebral haemorrhages occurred in 28 of 675 patients (4·1%, 95% CI 2·8-5·9) during 2010-13. In four Austrian states without similar stroke programmes, thrombolysis administration remained stable or declined between 2010 and 2013 (mean reduction 14·4%, 95% CI 10·9-17·9). Although the 3-month mortality was not affected by our programme (137 [13%] of 1060 patients in 2010 vs 143 [13%] of 1069 patients in 2013), 3-month functional outcome significantly improved (modified Rankin Scale score 0-1 in 375 [40%] of 944 patients in 2010 vs 493 [53%] of 939 in 2013; score 0-2 in 531 [56%] patients in 2010 and 615 [65%] in 2013; ptrend 2010-13<0·0001).During the period of implementation of our comprehensive stroke management programme, thrombolysis administration increased and clinical outcome significantly improved, although mortality did not change. We hope that these results will guide health authorities and stroke physicians elsewhere when implementing similar programmes for patients with stroke.Reformpool of the Tyrolean Health Care Fund." @default.
• W2151714333 created "2016-06-24" @default.
• W2151714333 creator A5002660861 @default.
• W2151714333 creator A5003589213 @default.
• W2151714333 creator A5005640059 @default.
• W2151714333 creator A5009628835 @default.
• W2151714333 creator A5010848236 @default.
• W2151714333 creator A5012116390 @default.
• W2151714333 creator A5016591599 @default.
• W2151714333 creator A5016839581 @default.
• W2151714333 creator A5019506878 @default.
• W2151714333 creator A5026038919 @default.
• W2151714333 creator A5026371413 @default.
• W2151714333 creator A5029004190 @default.
• W2151714333 creator A5030762923 @default.
• W2151714333 creator A5032051057 @default.
• W2151714333 creator A5040257365 @default.
• W2151714333 creator A5041864981 @default.
• W2151714333 creator A5047577512 @default.
• W2151714333 creator A5048212693 @default.
• W2151714333 creator A5051169384 @default.
• W2151714333 creator A5051669512 @default.
• W2151714333 creator A5056535306 @default.
• W2151714333 creator A5056772911 @default.
• W2151714333 creator A5057838135 @default.
• W2151714333 creator A5058720397 @default.
• W2151714333 creator A5059432127 @default.
• W2151714333 creator A5067319438 @default.
• W2151714333 creator A5067354048 @default.
• W2151714333 creator A5069334269 @default.
• W2151714333 creator A5070014340 @default.
• W2151714333 creator A5077356883 @default.
• W2151714333 creator A5078496504 @default.
• W2151714333 creator A5080567842 @default.
• W2151714333 creator A5080995864 @default.
• W2151714333 creator A5082584600 @default.
• W2151714333 creator A5085792808 @default.
• W2151714333 creator A5085996535 @default.
• W2151714333 creator A5086215751 @default.
• W2151714333 creator A5087411168 @default.
• W2151714333 creator A5088527030 @default.
• W2151714333 creator A5091042345 @default.
• W2151714333 date "2015-01-01" @default.
• W2151714333 modified "2023-10-13" @default.
• W2151714333 title "Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational study" @default.
• W2151714333 cites W1968877055 @default.
• W2151714333 cites W1970259047 @default.
• W2151714333 cites W1972214068 @default.
• W2151714333 cites W1973230551 @default.
• W2151714333 cites W1981986813 @default.
• W2151714333 cites W1987751736 @default.
• W2151714333 cites W1990714533 @default.
• W2151714333 cites W2003951897 @default.
• W2151714333 cites W2019146243 @default.
• W2151714333 cites W2045028900 @default.
• W2151714333 cites W2047943593 @default.
• W2151714333 cites W2055940399 @default.
• W2151714333 cites W2058175059 @default.
• W2151714333 cites W2060147844 @default.
• W2151714333 cites W2069149215 @default.
• W2151714333 cites W2084251269 @default.
• W2151714333 cites W2091095224 @default.
• W2151714333 cites W2091179058 @default.
• W2151714333 cites W2104542920 @default.
• W2151714333 cites W2110779488 @default.
• W2151714333 cites W2114969137 @default.
• W2151714333 cites W2119589894 @default.
• W2151714333 cites W2128968009 @default.
• W2151714333 cites W2130637270 @default.
• W2151714333 cites W2134590632 @default.
• W2151714333 cites W2138148586 @default.
• W2151714333 cites W2143277944 @default.
• W2151714333 cites W2148850185 @default.
• W2151714333 cites W2156075192 @default.
• W2151714333 cites W2161648295 @default.
• W2151714333 cites W2162257338 @default.
• W2151714333 cites W2164763924 @default.
• W2151714333 cites W2165568749 @default.
• W2151714333 cites W2170765765 @default.
• W2151714333 cites W2171165037 @default.
• W2151714333 cites W2292308933 @default.
• W2151714333 doi "https://doi.org/10.1016/s1474-4422(14)70286-8" @default.
• W2151714333 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25435129" @default.
• W2151714333 hasPublicationYear "2015" @default.
• W2151714333 type Work @default.
• W2151714333 sameAs 2151714333 @default.
• W2151714333 citedByCount "50" @default.
• W2151714333 countsByYear W21517143332015 @default.
• W2151714333 countsByYear W21517143332016 @default.
• W2151714333 countsByYear W21517143332017 @default.
• W2151714333 countsByYear W21517143332018 @default.
• W2151714333 countsByYear W21517143332019 @default.
• W2151714333 countsByYear W21517143332020 @default.
• W2151714333 countsByYear W21517143332021 @default.
• W2151714333 countsByYear W21517143332022 @default.
• W2151714333 countsByYear W21517143332023 @default.
• W2151714333 crossrefType "journal-article" @default.
• W2151714333 hasAuthorship W2151714333A5002660861 @default.

• next